# BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

> **NCT04150614** · PHASE4 · RECRUITING · sponsor: **University of Illinois at Chicago** · enrollment: 90 (estimated)

## Conditions studied

- Nausea With Vomiting Chemotherapy-Induced

## Interventions

- **DRUG:** Granisetron Transdermal Patch
- **DRUG:** Intravenous Dexamethasone
- **DRUG:** Ondansetron

## Key facts

- **NCT ID:** NCT04150614
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-14
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04150614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04150614, "BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04150614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*